Data / Form D filings / AlmataBio, Inc.
AlmataBio, Inc.: Form D filing
AlmataBio, Inc., a biotechnology company in Atlanta, GA, filed a Form D with the SEC in 2023. The latest, on December 4, 2023, reports $2.1 million sold of a $4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 650 PONCE DE LEON AVE, STE. 300 #3315, Atlanta, GA, 30308
- Phone
- (404) 793-2177
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2002604
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | New notice | $3,999,998 | $2,129,502 | $1,870,496 | 4 | Nov 22, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Justin J DiMartino | Executive Officer, Director, Promoter | |
| Patrick J Crutcher | Executive Officer, Director, Promoter |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Dec 4, 2023 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AlmataBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.